A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms.
A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Lille, FR · Author affiliation
Parkinson's Disease Centre of Excellence, Department of Neurology, Univ. Lille, Centre Hospitalier Universitaire Lille, INSERM U1172 - TREAT, Lille, France.Location evidence
Loos, FR · Author affiliation
InBrain Pharma, Loos, France.Location evidence
A plain-language reading has not been prepared for this paper yet.